A recent New York Times article highlighted the potentially under-reported side effect of Paradoxical Adipose Hyperplasia (PAH) associated with CoolSculpting treatments. This revelation is raising concerns among those considering non-invasive fat reduction options. In this blog post, we will discuss the potential under-reporting of PAH with CoolSculpting and explain how Cryoskin offers a safer alternative without this risk of PAH due to its unique, suction-free approach.
Understanding PAH
Paradoxical Adipose Hyperplasia (PAH) is a rare but distressing complication that can occur following CoolSculpting treatments. It involves the unexpected growth of fat cells in the treated area, resulting in a visibly enlarged and hardened mass. This outcome is contrary to the intended fat reduction and often leads to discomfort and dissatisfaction for those affected.
Under-Reporting of PAH with Coolsculpting
While PAH is considered rare, the New York Times article suggests that its incidence may be under-reported. Individuals affected by PAH may not report their experience due to embarrassment or lack of knowledge about the potential connection to CoolSculpting. Where Allergan (the owner of CoolSculpting) has helped cover the cost of corrective surgery "the payments are usually part of a settlement agreement which includes a confidentiality requirement" as stated by The New York Times.
Cryoskin: A Safer, Suction-Free Alternative
Cryoskin is a non-invasive fat reduction treatment that offers a safer alternative to CoolSculpting, without the risk of PAH. Cryoskin uses a handheld device that glides over the skin's surface, delivering precise and controlled cooling to the targeted fat cells. This suction-free approach differentiates Cryoskin from CoolSculpting and significantly reduces the likelihood of PAH.
Key reasons why Cryoskin doesn't have the same PAH risks as CoolSculpting
- No Suction: By eliminating suction from the treatment process, Cryoskin minimizes potential stress and trauma to the treated area, reducing the likelihood of PAH development. This gentle treatment allows for a more comfortable experience without compromising results.
- Controlled Application: Cryoskin's handheld device allows for better control and customization of the treatment, ensuring a more even and consistent application of cooling temperatures. This reduces the risk of overcooling or uneven treatment, which could potentially lead to PAH.
- Gradual Cooling: Cryoskin gradually lowers the temperature in the treated area, ensuring a more controlled and gentle cooling process. This gradual approach helps to minimize the risk of sudden temperature changes that could contribute to PAH.
Conclusion
The potential under-reporting of PAH as a side effect of CoolSculpting highlights the importance of being well-informed about the risks associated with non-invasive fat reduction treatments. Cryoskin offers a safer, suction-free alternative that significantly reduces the risk of PAH while still delivering effective and visible results. If you're considering a non-invasive fat reduction treatment, it's worth exploring Cryoskin as a safer option without the worry of PAH.
A Doctors science-based review of Cryoskin vs CoolSculpting:
https://www.youtube.com/watch?v=mUWRkyclo0E
